scholarly journals Aquatic mammal science in Latin America: a bibliometric analysis for the first eight years of the Latin American Journal of Aquatic Mammals (2002-2010)

2014 ◽  
Vol 9 (2) ◽  
pp. 42-64 ◽  
Author(s):  
Daniel M. Palacios ◽  
Cristiane C. A. Martins ◽  
Carlos Olavarría

We conducted a meta-analysis of the publication statistics for Vols. 1-8 of the Latin American Journal of Aquatic Mammals (LAJAM), the joint scholarly publication of the Sociedad Latinoamericana de Especialistas en Mamíferos Acuáticos and the Sociedad Mexicana de Mastozoología Marina, with the following purposes: (a) identifying the main patterns in the authorship and content published between 2002 and 2010, and (b) assessing the contributions of these scientific societies in the Latin American and global contexts. With the caveat that the results are only representative of the researchers that chose to publish in LAJAM during the period covered by the study, the metadata from 168 articles indicated that most of the research was conducted on small odontocetes (Sotalia, Pontoporia, Tursiops) and pinnipeds (Arctocephalus, Otaria, Mirounga) of coastal habits. Rorqual whales (Balaenoptera, Megaptera) and oceanic odontocetes (Stenella, Mesoplodon, Orcinus, Delphinus) also were well represented. Studies of distribution (including first records) were the most common, followed by those related to feeding, strandings, health and bycatch. Seventeen countries were represented in the primary affiliation of the lead author, but just five dominated the contribution: Brazil (52%), Argentina (10%), México (7%), Uruguay (5%) and USA (5%). Among institution types, a university was reported as the primary affiliation type by 50% of the authors, while 26% reported a NGO, 17% a government agency and 7% another type of organization. A social network analysis of 404 authors identified a large, well-connected cluster of 263 authors. Within this cluster, 13 authors from Brazil, Perú, Argentina and Colombia were among the most collaborative. The female to male ratio was 1:1.6 among lead authors and 1:3.2 among lead authors that published more than one article, suggesting a gender disparity within this scientific community. According to Google Scholar™, 91 articles in LAJAM were cited in other publications through January 2012, with an average of 7.5 citations per article. The 15 most cited articles had between 13 and 15 citations, were predominantly from Brazil, and were mainly about small cetaceans.

Author(s):  
Daniele Piovani ◽  
Claudia Pansieri ◽  
Soumya R R Kotha ◽  
Amanda C Piazza ◽  
Celia-Louise Comberg ◽  
...  

Abstract Background and aims The association between smoking and inflammatory bowel disease (IBD) relies on old meta-analyses including exclusively non-Jewish White populations. Uncertainty persists regarding the role of smoking in other ethnicities. Methods We systematically searched Medline/PubMed, Embase and Scopus for studies examining tobacco smoking and the risk of developing IBD, i.e., Crohn’s disease (CD) or ulcerative colitis (UC). Two authors independently extracted study data and assessed each study’s risk-of-bias. We examined heterogeneity and small-study effect, and calculated summary estimates using random-effects models. Stratified analyses and meta-regression were employed to study the association between study-level characteristics and effect estimates. The strength of epidemiological evidence was assessed through prespecified criteria. Results We synthesized 57 studies examining the smoking-related risk of developing CD and UC. Non-Jewish White smokers were at increased risk of CD (29 studies; RR: 1.95, 95% CI: 1.69‒2.24; moderate evidence). No association was observed in Asian, Jewish and Latin-American populations (11 studies; RR: 0.97; 95% CI: 0.83–1.13), with no evidence of heterogeneity across these ethnicities. Smokers were at reduced risk of UC (51 studies; RR: 0.55, 95% CI: 0.48–0.64; weak evidence) irrespectively of ethnicity; however, cohort studies, large studies and those recently published showed attenuated associations. Conclusions This meta-analysis did not identify any increased risk of CD in smokers in ethnicities other than non-Jewish Whites, and confirmed the protective effect of smoking on UC occurrence. Future research should characterize the genetic background of CD patients across different ethnicities to improve our understanding on the role of smoking in CD pathogenesis.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Bhaskar Thakur ◽  
Pallavi Dubey ◽  
Joseph Benitez ◽  
Joshua P. Torres ◽  
Sireesha Reddy ◽  
...  

AbstractSeveral comorbidities have been shown to be associated with coronavirus disease 2019 (COVID-19) related severity and mortality. However, considerable variation in the prevalence estimates of comorbidities and their effects on COVID-19 morbidity and mortality have been observed in prior studies. This systematic review and meta-analysis aimed to determine geographical, age, and gender related differences in the prevalence of comorbidities and associated severity and mortality rates among COVID-19 patients. We conducted a search using PubMed, Scopus, and EMBASE to include all COVID-19 studies published between January 1st, 2020 to July 24th, 2020 reporting comorbidities with severity or mortality. We included studies reporting the confirmed diagnosis of COVID-19 on human patients that also provided information on comorbidities or disease outcomes. We used DerSimonian and Laird random effects method for calculating estimates. Of 120 studies with 125,446 patients, the most prevalent comorbidity was hypertension (32%), obesity (25%), diabetes (18%), and cardiovascular disease (16%) while chronic kidney or other renal diseases (51%, 44%), cerebrovascular accident (43%, 44%), and cardiovascular disease (44%, 40%) patients had more COVID-19 severity and mortality respectively. Considerable variation in the prevalence of comorbidities and associated disease severity and mortality in different geographic regions was observed. The highest mortality was observed in studies with Latin American and European patients with any medical condition, mostly older adults (≥ 65 years), and predominantly male patients. Although the US studies observed the highest prevalence of comorbidities in COVID-19 patients, the severity of COVID-19 among each comorbid condition was highest in Asian studies whereas the mortality was highest in the European and Latin American countries. Risk stratification and effective control strategies for the COVID-19 should be done according to comorbidities, age, and gender differences specific to geographical location.


Author(s):  
Marcela Tamayo-Ortiz ◽  
Martha María Téllez-Rojo ◽  
Stephen J. Rothenberg ◽  
Ivan Gutiérrez-Avila ◽  
Allan Carpenter Just ◽  
...  

Exposure to PM2.5 has been associated with the prevalence of obesity. In the Greater Mexico City Area (GMCA), both are ranked among the highest in the world. Our aim was to analyze this association in children, adolescents, and adults in the GMCA. We used data from the 2006 and 2012 Mexican National Surveys of Health and Nutrition (ENSANUT). Participants’ past-year exposure to ambient PM2.5 was assessed using land use terms and satellite-derived aerosol optical depth estimates; weight and height were measured. We used survey-adjusted logistic regression models to estimate the odds ratios (ORs) of obesity (vs. normal-overweight) for every 10 µg/m3 increase in annual PM2.5 exposure for children, adolescents, and adults. Using a meta-analysis approach, we estimated the overall odds of obesity. We analyzed data representing 19.3 million and 20.9 million GMCA individuals from ENSANUT 2006 and 2012, respectively. The overall pooled estimate between PM2.5 exposure and obesity was OR = 1.96 (95% CI: 1.21, 3.18). For adolescents, a 10 µg/m3 increase in PM2.5 was associated with an OR of 3.53 (95% CI: 1.45, 8.58) and 3.79 (95% CI: 1.40, 10.24) in 2006 and 2012, respectively. More studies such as this are recommended in Latin American cities with similar air pollution and obesity conditions.


2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Lucas Bozzetti Pigozzi ◽  
Duziene Denardini Pereira ◽  
Marcos Pascoal Pattussi ◽  
Carmen Moret-Tatay ◽  
Tatiana Quarti Irigaray ◽  
...  

Abstract Aims To compare the difference in the quality of life between temporomandibular disorders (TMD) patients and non-TMD subjects diagnosed with the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) or the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD). Methods Medical Literature Analysis and Retrieval System Online (MEDLINE), Excerpta Medica database (EMBASE) and Latin American and Caribbean Health Sciences Literature (LILACS) databases were searched in studies published in English and Portuguese. The search was performed by two independent reviewers in duplicate. A manual search and the gray literature were also included. The inclusion criteria were clinical studies that used the RDC/TMD axis I and quality of life with standard questionnaires in young and middle-aged adult population (18–55 years). The data were analyzed quantitatively by combining the results in a meta-analysis using forest plots. The measure of effect used was the standardized mean difference (SMD) in depression levels. The Newcastle–Ottawa Scale (NOS) was used to evaluate the quality of the studies. The publication bias was assessed by funnel plots. The initial search included 806 articles without duplications. Results Twenty-four articles were included in the final systematic review. Of these, 9 were included in the meta-analysis, where it was shown a statistically significant in all axis I groups: (a) global TMD—groups I, II and III combined, N = 3829, SMD (95% CI) = 1.06 (0.65–1.51), p = 0.000; (b) group I—muscle disorders, N = 3,056, SMD (95% CI) = 0.82 (0.45–1.18), p = 0.000; (c) group II—disc displacements, N = 3,184, SMD (95% CI) = 0.59 (0.26–0.91), p = 0.000; and (d) group III—arthralgia/arthritis/arthrosis, N = 2781, SMD (95% CI) = 0.98 (0.59–1.36), p = 0.000. When compared to controls. Conclusions Quality of life is affected in all axis I TMD patients, especially in groups I and III with higher pain intensity and disability as compared to group II.


2021 ◽  
Vol 15 (5) ◽  
pp. 287-288
Author(s):  
Fabio A. Barbieri ◽  
José A. Barela ◽  
Natália M. Rinaldi

The Brazilian Journal of Motor Behavior (BJMB) is a quadriannual, peer-reviewed, free of charge/fee and open-access journal published by the Brazilian Society of Motor Behavior (SOCIBRACOM). The BJMB has published original contributions within the multidisciplinary study of human motor behavior, in the broad scope of motor control, development and learning, movement disorders, sports, clinical, theoretical and model studies. Since 2019 the BJMBpublishes manuscripts only in English. In the same year, BJMB started to invite researchers to be guest editors in article collections, providing an excellent opportunity to promote high-quality contents within the field. The BJMB is the main motor behavior journal in the Latin American. It is widely recognized for its significant academic contribution and indexed in the UlrichsWeb Global Serial Directory, Diadorium, Gale Directory Library, Google Scholar, Road Directory of Open Access Scholary resources and Red Iberoamericana de Innovación y Conocimiento Científico. The number of edition and papers has sustainable and significantly increased in the last years, with over 500 authors contributing with 121 manuscripts, distributed in 40 numbers. The time of peer-reviewed process is short (first revision- 26 days) and paper publication is quick (57 days). The BJMB was launched with its first edition published in December of 2006 and, thus, we are celebrating its 15thanniversary. For that, the BJMB launches a new type of manuscript: INFOGRAPHIC. This initiative aims to provide a quick, easy-to-use and enjoyable publication that conveys notable knowledge. Two types of infographics will be publishable: a) theory perspective: visual material to theory acknowledge to facilitate the understanding of models, theory frameworks, concepts, principles, and approaches in the field; b) article infographic: visual material about interventional effects on motor learning, development and control sustained by reviews and/or meta-analysis. The infographic section will be added to those already existing: research, systematic review and meta-analysis, mini review, scoping review, research notes, current opinion, critique, and tutorials. It is interesting to highlight the section about tutorial, which emphasizes and provides reflection on the use of one or several methods or self-instruction in motor behavior. Finally, the current opinion section publishes pieces of diverse authors around the world that provide perspectives on a hot, relevant, and perhaps controversial topic within the scope of BJMB. We would like to congratulate all for this important occasion and to wish that the BJMB continues publishing impactful and relevant contributions in the motor behavior field still for many years to come.


2019 ◽  
Vol 130 (4) ◽  
pp. 1065-1079 ◽  
Author(s):  
Michael C. Dewan ◽  
Abbas Rattani ◽  
Rania Mekary ◽  
Laurence J. Glancz ◽  
Ismaeel Yunusa ◽  
...  

OBJECTIVEHydrocephalus is one of the most common brain disorders, yet a reliable assessment of the global burden of disease is lacking. The authors sought a reliable estimate of the prevalence and annual incidence of hydrocephalus worldwide.METHODSThe authors performed a systematic literature review and meta-analysis to estimate the incidence of congenital hydrocephalus by WHO region and World Bank income level using the MEDLINE/PubMed and Cochrane Database of Systematic Reviews databases. A global estimate of pediatric hydrocephalus was obtained by adding acquired forms of childhood hydrocephalus to the baseline congenital figures using neural tube defect (NTD) registry data and known proportions of posthemorrhagic and postinfectious cases. Adult forms of hydrocephalus were also examined qualitatively.RESULTSSeventy-eight articles were included from the systematic review, representative of all WHO regions and each income level. The pooled incidence of congenital hydrocephalus was highest in Africa and Latin America (145 and 316 per 100,000 births, respectively) and lowest in the United States/Canada (68 per 100,000 births) (p for interaction < 0.1). The incidence was higher in low- and middle-income countries (123 per 100,000 births; 95% CI 98–152 births) than in high-income countries (79 per 100,000 births; 95% CI 68–90 births) (p for interaction < 0.01). While likely representing an underestimate, this model predicts that each year, nearly 400,000 new cases of pediatric hydrocephalus will develop worldwide. The greatest burden of disease falls on the African, Latin American, and Southeast Asian regions, accounting for three-quarters of the total volume of new cases. The high crude birth rate, greater proportion of patients with postinfectious etiology, and higher incidence of NTDs all contribute to a case volume in low- and middle-income countries that outweighs that in high-income countries by more than 20-fold. Global estimates of adult and other forms of acquired hydrocephalus are lacking.CONCLUSIONSFor the first time in a global model, the annual incidence of pediatric hydrocephalus is estimated. Low- and middle-income countries incur the greatest burden of disease, particularly those within the African and Latin American regions. Reliable incidence and burden figures for adult forms of hydrocephalus are absent in the literature and warrant specific investigation. A global effort to address hydrocephalus in regions with the greatest demand is imperative to reduce disease incidence, morbidity, mortality, and disparities of access to treatment.


2019 ◽  
Vol 07 (12) ◽  
pp. E1704-E1713 ◽  
Author(s):  
Daniel Tavares de Rezende ◽  
Vitor Ottoboni Brunaldi ◽  
Wanderley Marques Bernardo ◽  
Igor Braga Ribeiro ◽  
Raquel Cristina Lins Mota ◽  
...  

Abstract Background and study aims TC-325 is a novel mineral hemostatic powder that creates a mechanical barrier by absorbing blood components and promoting clotting. Recently approved for use in humans, it has shown promise for treatment of upper gastrointestinal bleeding (UGIB). However, because there have been no large studies of TC-325, its true efficacy and safety profile remain unknown. We performed a systematic review and meta-analysis to determine the safety and efficacy of TC-325 in treating UGIB, based on rates of initial hemostasis, rebleeding, and adverse events (AEs). Methods We searched the MEDLINE/PubMed, EMBASE, CENTRAL, Latin-American and Caribbean Health Sciences Literature databases, as well as the gray literature, to identify articles describing use of TC-325 up to October 2018. Primary outcomes were initial hemostasis and rebleeding. AEs were described as a secondary outcome. Risk of bias was assessed with international scores. Results We identified 2077 records after removal of duplicates. We included 50 studies, involving a collective total of 1445 patients, in the quantitative synthesis. Primary hemostasis and rebleeding rates were 90.7 % and 26.1 %, respectively. Subgroup analyses showed similar results. Only eight AEs were reported. Conclusions TC-325 appears to be a safe, effective treatment for UGIB. The overall rate of initial hemostasis after TC-325 use is high, regardless of etiology of bleeding or whether TC-325 is used as a primary or rescue therapy. Although it is also associated with high rebleeding rates, rates of AEs and equipment failure after TC-325 use are extremely low.


BMJ Open ◽  
2020 ◽  
Vol 10 (5) ◽  
pp. e031850 ◽  
Author(s):  
Irene B Murimi-Worstell ◽  
Dora H Lin ◽  
Henk Nab ◽  
Hong J Kan ◽  
Oluwadamilola Onasanya ◽  
...  

ObjectiveAt least half of patients with systemic lupus erythematosus (SLE) develop organ damage as a consequence of autoimmune disease or long-term therapeutic steroid use. This study synthesised evidence on the association between organ damage and mortality in patients with SLE.DesignSystematic review and meta-analysis.MethodsElectronic searches were performed in PubMed, Embase, Cochrane Library and Latin American and Caribbean Health Sciences Literature for observational (cohort, case-control and cross-sectional) studies published between January 2000 and February 2017. Included studies reported HRs or ORs on the association between organ damage (measured by the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) score) and mortality. Study quality was assessed using the modified Newcastle-Ottawa assessment. Pooled HRs were obtained using the DerSimonian and Laird random-effects model. Heterogeneity was assessed using the Cochrane Q (Q) and I2 statistics.ResultsThe search yielded 10 420 articles, from which 21 longitudinal studies were selected. Most studies (85%) were of high quality. For 10 studies evaluating organ damage (SDI) as a continuous variable and reporting HR as a measure of association, a 1-unit increase in SDI was associated with increased mortality; pooled HR was 1.34 (95% CI: 1.24 to 1.44, p<0.001; Q p=0.027, I2=52.1%). Exclusion of one potential outlying study reduced heterogeneity with minimal impact on pooled HR (1.33 (95% CI: 1.25 to 1.42), p<0.001, Q p=0.087, I2=42.0%). The 11 remaining studies, although they could not be aggregated because of their varying patient populations and analyses, consistently demonstrated that greater SDI was associated with increased mortality.ConclusionsOrgan damage in SLE is consistently associated with increased mortality across studies from various countries. Modifying the disease course with effective therapies and steroid-sparing regimens may reduce organ damage, improve outcomes and decrease mortality for patients with SLE.


2019 ◽  
Vol 8 (1) ◽  
Author(s):  
Denise Grotto ◽  
Isabella Ferreira Camargo ◽  
Katia Kodaira ◽  
Lauren Giustti Mazzei ◽  
Juliana Castro ◽  
...  

Abstract Background Obesity and its consequences are worldwide epidemic problem; therefore, studies with strategies and mechanisms that favor weight loss to improve outcomes in health are necessary. Effects of mushrooms on body weight are uncertain. The aim of this systematic review is to determine the efficacy of mushrooms in weight loss in animal preclinical models. Method This is a systematic review of preclinical studies of animal models of obesity (any type of non-aquatic mammal), which were exposed to edible and medicinal mushrooms orally in comparison with the control. The following databases will be used: MEDLINE (PubMed), Web of Science, BIOSIS, SCOPUS, and gray literature. There will be no restriction of language, date, or publication status. The primary outcome will be body weight loss. And the secondary outcomes include the total amount of food consumed by the animals, analysis of metabolic parameters, inflammatory mediators, mortality for any causes, and any adverse effect reported. A team of reviewers will select, in pairs and independently, the titles and abstracts, extract data from qualifying studies, and assess bias risk (using SYstematic Review Centre for Laboratory animal Experimentation SYRCLE’s risk of bias tool and the Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies (CAMARADES) checklist). The standardized mean difference (SMD) will be calculated to measure treatment effect, with 95% confidence intervals (95% CI). The heterogeneity between-study will be calculated by I2 inconsistency values and Cochran’s Q statistical test, where I2 > 50% and/or p < 0.10 suggest high heterogeneity meta-analyses of random effects will be conducted as possible. Discussion Although many experimental studies about the effects of mushrooms on obesity have already been published, there is still no consensus in the literature. This study will provide evidences of preclinical research on mushrooms and their relation to body weight loss in animal models of obesity, being non-aquatic mammals. Also, this systematic review will show the limitations and strengths of the studies available in the literature, as well as it will to encourage the financing of new studies by public health managers and governmental entities. Systematic review registration PROSPERO (CRD42019125299).


PLoS ONE ◽  
2016 ◽  
Vol 11 (10) ◽  
pp. e0164903 ◽  
Author(s):  
Thais Gimenez ◽  
Beatriz Albuquerque Bispo ◽  
Daniela Pereira Souza ◽  
Maria Eduarda Viganó ◽  
Marcia Turolla Wanderley ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document